Toronto Dominion Bank
LGND icon

Toronto Dominion Bank’s Ligand Pharmaceuticals LGND Stock Holding History

Toronto Dominion Bank’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,070
Closed -$1.36M – 1734
2021
Q4 		$1.36M Buy
+14,070
New +$1.3M ﹤0.01% 945

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Toronto Dominion Bank's LGND Position: Q1 2022 in Review

Toronto Dominion Bank sold out of Ligand Pharmaceuticals (LGND) in Q1 2022, closing a stake of 14,070 shares — an estimated $1.36M sold.

Toronto Dominion Bank first reported a position in LGND in Q4 2021 and held it in 1 quarter. The position peaked at $1.36M in Q4 2021. 208 funds tracked by Wall St. Rank hold LGND as of Q1 2022.

  • Toronto Dominion Bank reported no remaining Ligand Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Toronto Dominion Bank sold 14,070 Ligand Pharmaceuticals shares in Q1 2022, an estimated $1.36M.
  • Toronto Dominion Bank first reported a position in Ligand Pharmaceuticals in Q4 2021 and held it in 1 quarter.
  • Toronto Dominion Bank's Ligand Pharmaceuticals position peaked at $1.36M in Q4 2021.
  • 208 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2022.

Based on Toronto Dominion Bank's 13F filing for Q1 2022, filed 9 May 2022.